UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000014560 |
|---|---|
| Receipt number | R000016925 |
| Scientific Title | Phase 1/2 study of triple combination chemotherapy with Carboplatin, nab-Paclitaxel, and Bevacizumab for chemotherapy-naïve stageIIIB/IV non- squamous non-small-cell lung cancer (TORG1424/OLCSG1402) |
| Date of disclosure of the study information | 2014/07/30 |
| Last modified on | 2019/04/24 09:28:43 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/07/15 13:40:55 | ||
| 2 | Update | 2014/10/30 14:03:26 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2016/05/19 13:31:29 | Name of primary person or sponsor Organization |
|
| 4 | Update | 2018/10/24 10:36:08 | Recruitment status |
|
| 5 | Update | 2019/04/24 09:28:43 | Recruitment status Date of IRB Last follow-up date |
